IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 250 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,732,437 | -64.7% | 179,900 | -61.1% | 0.94% | -56.8% |
Q2 2023 | $4,914,616 | -13.7% | 461,900 | -14.7% | 2.19% | -1.7% |
Q1 2023 | $5,693,424 | +31.0% | 541,200 | +54.3% | 2.22% | +52.6% |
Q4 2022 | $4,345,173 | +38.4% | 350,700 | +15.7% | 1.46% | +50.5% |
Q3 2022 | $3,139,000 | +51.0% | 303,000 | +68.1% | 0.97% | +131.0% |
Q2 2022 | $2,079,000 | – | 180,300 | – | 0.42% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HealthInvest Partners AB | 1,520,000 | $19,562,000 | 18.54% |
Sarissa Capital Management LP | 16,390,000 | $210,939,000 | 16.77% |
Healthcare Value Capital, LLC | 200,000 | $2,574,000 | 5.13% |
Camber Capital Management LP | 7,500,000 | $96,525,000 | 3.25% |
13D Management LLC | 650,455 | $8,371,000 | 2.88% |
BRIDGER MANAGEMENT, LLC | 2,035,114 | $26,192,000 | 2.44% |
Brown Capital Management | 18,484,759 | $237,899,000 | 1.80% |
Healthcare Value Capital, LLC | 50,000 | $644,000 | 1.28% |
Zebra Capital Management LLC | 53,359 | $687,000 | 0.80% |
PRICE MICHAEL F | 520,000 | $6,692,000 | 0.74% |